Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • Businesses Solutions • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Investment Management • Consumer • Pharmaceutical (& Medicine) |
Stages | Seed, Startup, Early Stage, Expansion, Later Stage, Recapitalization, Special Situations, PIPE, Spinout, Series A |
Investing | United States • Europe • Ireland |
Investment Range | $100,000 - $5,000,000 |
Investment Sweet Spot | $1,500,000 |
Assets Under Management | $1,200,000,000 |
Longitude Capital is a Venture Capital fund specializing in Equity and Royalties with expertise in investing across the BioTech, Businesses Solutions, HealthTech (& Fitness), Medical Devices (& Hospital Services), Healthcare (& Wellness), Investment Management, Pharmaceutical (& Medicine), and Consumer industries. The firm is known for its venture growth strategy and invests in transformative healthcare companies, focusing on those that improve clinical outcomes, enhance quality of life for patients, and aim to reduce the cost of care. They engage in equity investments, royalties, and asset spin-outs, as well as recapitalizations, PIPEs, open market purchases, and other equity-linked instruments. Since their inception in 2006, Longitude Capital has raised over $2 billion across six funds, targeting investments in clinically de-risked assets, favorable risk-reward evaluations, with attractive expected returns within a typical three to five-year exit time frame. They actively invest in both privately held and publicly traded entities, with a flexible approach ranging from seed to later stage investments. Their investment sweet spot is $1.5 million, while they are capable of investing from $100,000 up to a maximum of $5 million. Additionally, Longitude Capital focuses on building strategic partnerships and working closely with portfolio companies to optimize returns for stakeholders. Their team, with over 200 years of combined investing experience, operates from offices in Menlo Park, California and Boston, Massachusetts. The fund's name, inspired by the Longitude Prize, reflects their commitment to solving significant problems through strategic investments.